thiazoles has been researched along with abt-199 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brors, B; Huber, W; Hüllein, J; Kurilov, R; Lee, KS; Lukas, M; Oleś, M; Sellner, L; Tomska, K; Wagner, L; Walther, T; Zenz, T | 1 |
| Chaudhari, RR; Chen, R; Chen, Y; Hull, KG; Plunkett, W; Qin, Q; Robles, O; Romo, D; Skillern, W; Wierda, WG; Zhang, S; Zhu, M | 1 |
| Edwards, H; Ge, Y; Knight, T; Lin, H; Liu, F; Su, Y; Sun, L; Taub, JW; Wang, G; Wang, Y | 1 |
| Albert, R; Alcon, C; Gómez Tejeda Zañudo, J; Letai, A; Montero, J; Samitier, J; Scaltriti, M; Wagle, N | 1 |
4 other study(ies) available for thiazoles and abt-199
| Article | Year |
|---|---|
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma.
Topics: Acetanilides; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Burkitt Lymphoma; Cell Line, Tumor; Drug Combinations; Drug Synergism; Heterocyclic Compounds, 3-Ring; Humans; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles | 2018 |
Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Apoptosis; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Drug Synergism; Drug Therapy, Combination; Epoxy Compounds; Eukaryotic Initiation Factor-4A; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Macrolides; Male; Middle Aged; Models, Molecular; Myeloid Cell Leukemia Sequence 1 Protein; Prognosis; Protein Biosynthesis; Protein Conformation; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sulfonamides; Thiazoles; Tumor Cells, Cultured | 2019 |
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Naphthyridines; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles; Tumor Cells, Cultured; Young Adult | 2019 |
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Estrogen Receptor alpha; Everolimus; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Myeloid Cell Leukemia Sequence 1 Protein; Piperazines; Protein Isoforms; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; Sulfonamides; Thiazoles; Thiophenes | 2021 |